Skip to content

Vitamin D Inadequacy is Associated With Incidence of Type 2 Diabetes

Vitamin D Inadequacy is Associated With Incidence of Type 2 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01508481
Enrollment
1500
Registered
2012-01-12
Start date
2007-01-31
Completion date
2012-10-31
Last updated
2012-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Vitamin D, Diabetes, pancreas beta cell function, insulin resistance, Deficiency of Vitamin D3

Brief summary

Emerging evidence suggests that vitamin D \[25-hydroxyvitamin D; 25(OH)D\] may play a role in the etiology of type 2 diabetes. Vitamin D levels are lower in those with type 2 diabetes and impaired glucose tolerance (IGT) compared with those with normal glucose tolerance (NGT). In addition, a few prospective studies have shown a significant inverse association of baseline serum 25(OH)D with incident diabetes. To date, however, the exact mechanisms through which vitamin D affects diabetes risk are not yet fully known, particularly whether vitamin D plays a role in insulin resistance (IR) and/or b-cell dysfunction, the main pathophysiological disorders underlying type 2 diabetes. So, the investigators plan to examine the prospective associations of baseline vitamin D \[25-hydroxyvitamin D; 25(OH)D\] with insulin resistance (IR), b-cell function, and glucose homeostasis in subjects at risk for type 2 diabetes.

Interventions

None listed

Sponsors

Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* one or more risk factors for diabetes, including: * obesity * hypertension * dislipidemia * a family history of diabetes

Exclusion criteria

* previous diagnosed diabetes * vitamin D supplement.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of diabetes5 yearsIncidence of diabetes defined by American Diabetes Association criteria

Secondary

MeasureTime frameDescription
Pancreatic beta cell function5 yearsPancreatic beta cell function assessed by homeostasis model
Insulin resistance5 yearsInsulin resistance assessed by homeostasis model

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026